These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4756131)

  • 1. Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
    Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
    Brain Res; 1973 Aug; 58(2):291-301. PubMed ID: 4756131
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 6-hydroxydopamine on the nature of proteins undergoing axoplasmic transport in nigro-neostriatal neurons.
    Singh VK; Fibiger HC; McGeer PL
    J Neurochem; 1974 Sep; 23(3):601-4. PubMed ID: 4153672
    [No Abstract]   [Full Text] [Related]  

  • 3. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.
    Sotelo C; Javoy F; Agid Y; Glowinski J
    Brain Res; 1973 Aug; 58(2):269-90. PubMed ID: 4756130
    [No Abstract]   [Full Text] [Related]  

  • 6. Injection of 6-hydroxydopamine and hydrogen peroxide into the substantia nigra and lateral ventricle of the cat: specific and nonspecific effects on striatal biogenic amines.
    Stahl SM; Daniels AC; Derda D; Spehlmann R
    J Neurochem; 1975 Jan; 24(1):165-72. PubMed ID: 1110359
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine.
    White NM
    Life Sci; 1988; 43(1):7-12. PubMed ID: 3133532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Hydroxydopamine and striatal acetylcholine levels.
    Grewaal DS; Fibiger HC; McGeer EG
    Brain Res; 1974 Jun; 73(2):372-5. PubMed ID: 4151550
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors.
    Mishra RK; Wong YW; Varmuza SL; Tuff L
    Life Sci; 1978 Aug; 23(5):443-6. PubMed ID: 692267
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
    Kelly PH; Joyce EM; Minneman KP; Phillipson OT
    Brain Res; 1977 Feb; 122(2):382-7. PubMed ID: 189878
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis.
    Levine RA; Miller LP; Lovenberg W
    Science; 1981 Nov; 214(4523):919-21. PubMed ID: 6117945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 13. Changed eating and locomotor behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra.
    Brook C; Iversen SD
    Neuropharmacology; 1975 Feb; 14(2):95-105. PubMed ID: 1171387
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra.
    Robertson GS; Herrera DG; Dragunow M; Robertson HA
    Eur J Pharmacol; 1989 Jan; 159(1):99-100. PubMed ID: 2495972
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotation produced by administration of dopamine and related substances directly into the supersensitive caudate nucleus.
    Setler PE; Malesky M; McDevitt J; Turner K
    Life Sci; 1978 Sep; 23(12):1277-84. PubMed ID: 713698
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
    Agid Y; Javoy F; Glowimski J
    Brain Res; 1974 Jul; 74(1):41-9. PubMed ID: 4847602
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of the effect on the avoidance conditionning of microinjections of 6-hydroxydopamine in rat nigro-striatal system].
    Echavarria-Mage MT; Senault B; Delacour J
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):905-7. PubMed ID: 820478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.